T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Leukemia

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2402401PMID 11960352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defective Cytochrome c-dependent Caspase Activation in Ovarian Cancer Cell Lines due to Diminished or Absent Apoptotic Protease Activating Factor-1 Activity*

  2001cited by this paper
• Endonuclease G is an apoptotic DNase when released from mitochondria

  2001cited by this paper
• Caspase Activation Is Required for Terminal Erythroid Differentiation

  2001cited by this paper
• Cleavage of the Serum Response Factor during Death Receptor-induced Apoptosis Results in an Inhibition of the c-FOS Promoter Transcriptional Activity*

  2000cited by this paper
• Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

  2000cited by this paper
• Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line

  2000cited by this paper
• Cell death beyond apoptosis

  2000cited by this paper
• Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma.

  1999cited by this paper
• Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: A novel mechanism of nuclear apoptosis resistance.

  1999cited by this paper
• Apoptosis: Cutting red-cell production

  1999cited by this paper
• Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

  1999cited by this paper
• A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis

  1999cited by this paper
• Cleavage and relocation of the tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes

  1999cited by this paper
• Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

  1999cited by this paper
• Apoptotic nuclear morphological change without DNA fragmentation.

  1999cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• An Induced Proximity Model for Caspase-8 Activation*

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model

  1998cited by this paper
• Binding of anti-CD23 monoclonal antibody to the leucine zipper motif of FcepsilonRII/CD23 on B cell membrane promotes its proteolytic cleavage. Evidence for an effect on the oligomer/monomer equilibrium.

  1998cited by this paper
• Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis.

  1998cited by this paper
• T-Cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck.

  1998cited by this paper
• CD10 is expressed on human thymic epithelial cell lines and modulates thymopentin‐induced cell proliferation

  1997cited by this paper
• Endopeptidase 24.11 (CD10/NEP) is required for phorbol ester‐induced growth arrest in Jurkat T cells

  1997cited by this paper
• Identification and mapping of Casp7, a cysteine protease resembling CPP32β, interleukin-1β converting enzyme, and CED-3

  1997cited by this paper
• Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1 beta converting enzyme, and CED-3.

  1997cited by this paper
• FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

  1996cited by this paper
• Tyrosine Phosphorylation of I?B-a Activates NF-?B without Proteolytic Degradation of I?B-a

  1996cited by this paper
• Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

  1996cited by this paper
• Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.

  1996cited by this paper
• Pivotal role of a DEVD‐sensitive step in etoposide‐induced and Fas‐mediated apoptotic pathways.

  1996cited by this paper
• Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

  1996cited by this paper
• FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*)

  1996cited by this paper
• FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• CD20 monoclonal antibodies stimulate extracellular cleavage of the low affinity receptor for IgE (Fc epsilon RII/CD23) in Epstein-Barr-transformed B cells.

  1994cited by this paper
• Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.

  1993cited by this paper
• Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation.

  1992cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper

• Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials

  2024cites this paper
• DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.

  2021cites this paper
• The role of the DFF40/CAD endonuclease in genomic stability

  2021cites this paper
• DNA FRAGMENTATION FACTOR 40 EXPRESSION IN T CELLS CONFER SENSIBILITY TO TRIBUTYLTIN-INDUCED APOPTOSIS.

  2019cites this paper
• Transcriptome analysis of ABCB1, ABCG2 and the BCL2/BAX ratio in refractory and relapsed canine lymphomas under treatment and rescue protocol

  2018cites this paper
• Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

  2018cites this paper
• Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis

  2016cites this paper
• Radiotherapy and TRAIL for cancer therapy.

  2013cites this paper
• Characterisation of SHIP-1 as a regulator of T lymphocyte function

  2010cites this paper
• Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins

  2010cites this paper
• Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation

  2010cites this paper
• Dual Role of Sp3 Transcription Factor as an Inducer of Apoptosis and a Marker of Tumour Aggressiveness

  2009cites this paper
• Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

  2009cites this paper
• Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions

  2009cites this paper
• Involvement of CD45 in DNA fragmentation in apoptosis induced by mitochondrial perturbing agents

  2008cites this paper
• Differential effects of chemotherapeutic drugs versus the MDM‐2 antagonist nutlin‐3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B‐cells

  2008cites this paper
• Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo

  2006cites this paper
• Correlation between decreased sensitivity of the Daudi lymphoma cells to VP-16-induced apoptosis and deficiency in DNAS1L3 expression.

  2006cites this paper
• p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.

  2006cites this paper
• Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.

  2006cites this paper
• Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B‐cell lymphomas, determined by a highly sensitive in vitro apoptosis assay

  2006cites this paper
• In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation.

  2006cites this paper
• In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline: Involvement of caspase cascades and IκBα phosphorylation

  2006cites this paper
• Tumor intracellular redox status and drug resistance--serendipity or a causal relationship?

  2004cites this paper
• Differential DNases are selectively used in neuronal apoptosis depending on the differentiation state

  2004cites this paper
• PAP Modulations in Daudi Cells and Molt-3 Cells Treated with Etoposide are Mutually Associated with Morphological Evidence of Apoptosis

  2004cites this paper
• PAP modulations in Daudi cells and Molt-3 cells treated with etoposide are mutually associated with morphological evidence of apoptosis.

  2004cites this paper
• Regulation of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced apoptosis in Burkitt's lymphoma cell lines

  2003cites this paper
• Localization of TRAIL/TRAILR in fetal pancreas.

  2003cites this paper
• The P54‐cleaved form of the tyrosine kinase Lyn generated by caspases during BCR‐induced cell death in B lymphoma acts as a negative regulator of apoptosis

  2003cites this paper
• Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.

  2003cites this paper
• Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function

  2003cites this paper